glucagon glp 1 Glucagon-like peptide-1 GLP-1 Human (31 a.a.)

The fact that retatrutide has shown weight loss potentially exceeding both CagriSema and tirzepatide suggests that more receptor targets may indeed produce better outcomes

I think at this point if the "standard of care" does not include a mandatory RT program (especially for older individuals), the doctors should be sued for malpractice

Administering a low dose of the injection below the standard dose

When I work with patients to encourage weight loss, I first consider any underlying disease processes we need to reduce: A patient with mild hypertension may respond favorably to a 5% weight loss, or even slightly less

doi: 10.2147/TCRM 117 GrugniGGiardinoDCrinAMalvestitiFBallaratiLDi GiorgioGet al